{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:32:02Z","timestamp":1791977522938,"version":"4.4.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Pancreatitis is a known side effect of the once commonly used drug, sodium stibogluconate, for treatment of visceral leishmaniasis (VL). In India, miltefosine has recently been introduced as the first-line drug. Its side effects include loose motions, vomiting, and teratogenicity. We report here a case of a 41-year-old parasitologically confirmed male case of VL, who developed acute pancreatitis during treatment with miltefosine. On the 13\n                      <jats:sup>th<\/jats:sup>\n                      day of treatment, he presented with abdominal pain and vomiting. The biochemical, hematological, and radiological features were suggestive of acute pancreatitis. The patient was put on conservative treatment for pancreatitis at the specialized center but succumbed to renal failure and septicaemia.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0022-3859.123161","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T04:35:24Z","timestamp":1387254924000},"page":"306-308","source":"Crossref","is-referenced-by-count":9,"title":["Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment"],"prefix":"10.4103","volume":"59","author":[{"given":"K","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CS","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VNR","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20240205","first-page":"195","article-title":"Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible and operationally achievable","volume":"123","author":"Bhattacharya","year":"2006","journal-title":"Indian J Med Res"},{"key":"R2-11-20240205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/clind\/16.3.397","article-title":"Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate","volume":"16","author":"Halim","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R3-11-20240205","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/clinids\/21.3.710","article-title":"Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate","volume":"21","author":"McBride","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R4-11-20240205","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0016-5085(91)90089-4","article-title":"Lipase\/amylase ratio. A new index that distinguishes acute episodes of alcoholic from nonalcoholic acute pancreatitis","volume":"101","author":"Gumaste","year":"1991","journal-title":"Gastroenterology"},{"key":"R5-11-20240205","first-page":"131","article-title":"Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar","volume":"18","author":"Das","year":"2005","journal-title":"Natl Med J India"},{"key":"R6-11-20240205","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.gie.2007.09.007","article-title":"MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: Long-term outcomes","volume":"67","author":"Testoni","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"R7-11-20240205","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"Bhattacharya","year":"2007","journal-title":"J Infect Dis"},{"key":"R8-11-20240205","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/archinte.1996.00440090141020","article-title":"Acute pancreatitis associated with sodium stibogluconate treatment in a patient with human immunodeficiency virus","volume":"156","author":"Domingo","year":"1996","journal-title":"Arch Intern Med"}],"container-title":["Journal of Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005257-201359040-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:59:11Z","timestamp":1786647551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005257-201359040-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.4103\/0022-3859.123161","relation":{},"ISSN":["0022-3859"],"issn-type":[{"value":"0022-3859","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}